Related references
Note: Only part of the references are listed.An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis
AMLO Lashof et al.
EUROPEAN JOURNAL OF CANCER (2004)
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer
MC Dahiya et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
The changes in irradiated salivary gland function of patients with head and neck tumors treated with radiotherapy
M Someya et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2003)
Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers
M Koc et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2003)
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
MA Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis
JL Lefebvre et al.
ORAL ONCOLOGY (2002)
Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer
SW Redding et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis
J Taillandier et al.
AGE AND AGEING (2000)
Share Paper
